News

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.

A new technology disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.

Discover how bioinformatics in drug discovery is accelerating innovations in spinal cord injury treatment with thiorphan.

State-of-the-art AI programs can support the development of drugs. However, researchers at the University of Basel have shown that these programs only memorize patterns, rather than understanding physical relationships.

In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common chemotherapy drug, making it dramatically more soluble and effective and less toxic.

Federally funded research in mice shows neurons regulate osteosarcoma progression, suggesting that inhibiting nerve signaling might improve patient outcomes.

New research shows that a rare brain cell is abnormally active in mice with schizophrenia-like behavior, and reducing the activity of these cells alters mouse behavior.

New research identifies why some cancer patients get heart damage during chemotherapy, offering hope for protecting the heart during treatment.

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE.

The mirror form of cysteine has been shown to slow the growth of cancer cells, while sparing healthy ones.